Yilmaz A, Yilmaz S, Kallio E, Rapola J, Häyry P
Transplantation Laboratory, University of Helsinki, Finland.
Transplantation. 1995 Dec 15;60(11):1314-22.
We have investigated the evolution of chronic glomerular changes in the absence of the recurrence of original disease in an experimental rat model of chronic renal allograft rejection. Using serial graft needle biopsies and serum creatinine levels, we were able to focus on early glomerular changes that are associated with good graft function. The recipient rats were divided into 5 groups, 2 with allogeneic (DA to WF) transplants and 3 with syngeneic (DA to DA) transplants. In the first 2 allogeneic groups, one group received cyclosporine (CsA) for 2 weeks (n = 7) and the other received CsA for 12 weeks (n = 5). In the 2-week treatment group, all allografts developed chronic rejection, compared with none in the 12-week group. Syngeneic controls received CsA for 2 (n = 3) and 12 weeks (n = 3), or no immunosuppression (n = 2) in order to exclude the effects of CsA. The first detectable ultrastructural event was slight deposition of electron lucent material in the glomerular basement membrane. Contrary to previous morphological studies, the initial deposition was not subendothelial, but was within the lamina densa itself. Examination of allogeneic grafts with good graft function and syngeneic grafts showed glomerular alterations that were similar to the early changes preceding chronic rejection. The intensity of changes in optimally immunosuppressed allografts was mild, and they were arrested early in the evolving stage of glomerular basement membrane changes. In the suboptimally immunosuppressed allografts with chronic rejection, the glomerular basement membrane changes became more pronounced and extensive in subsequent biopsies. Thus, all recipients in different groups showed similar glomerular alterations, but to different intensities. These results suggest a common pathogenetic mechanism which might be endothelial damage. In chronic rejection, the endothelial damage might be immunologically mediated by rejection episodes and progressive, whereas in syngeneic grafts and in allografts without chronic rejection, perioperative trauma, ischemia, and graft reperfusion may be responsible for the self-limiting glomerular changes.
我们在慢性肾移植排斥反应的实验大鼠模型中,研究了在原发病不复发的情况下慢性肾小球变化的演变。通过系列移植针活检和血清肌酐水平,我们能够关注与良好移植肾功能相关的早期肾小球变化。将受体大鼠分为5组,2组进行同种异体(从DA到WF)移植,3组进行同基因(从DA到DA)移植。在前两个同种异体移植组中,一组接受环孢素(CsA)治疗2周(n = 7),另一组接受CsA治疗12周(n = 5)。在2周治疗组中,所有同种异体移植均发生慢性排斥反应,而12周组无一例发生。同基因对照组接受CsA治疗2周(n = 3)和12周(n = 3),或不进行免疫抑制(n = 2),以排除CsA的影响。首次可检测到的超微结构事件是肾小球基底膜中出现轻度电子透亮物质沉积。与先前的形态学研究相反,初始沉积不是在内皮下,而是在致密层本身内。对具有良好移植肾功能的同种异体移植和同基因移植进行检查,发现肾小球改变与慢性排斥反应之前的早期变化相似。最佳免疫抑制的同种异体移植中的变化强度较轻,并且在肾小球基底膜变化的演变阶段早期就停止了。在发生慢性排斥反应的免疫抑制不足的同种异体移植中,在随后的活检中肾小球基底膜变化变得更加明显和广泛。因此,不同组中的所有受体均显示出相似的肾小球改变,但强度不同。这些结果提示了一种可能是内皮损伤的共同发病机制。在慢性排斥反应中,内皮损伤可能由排斥反应事件免疫介导且呈进行性,而在同基因移植和无慢性排斥反应的同种异体移植中,围手术期创伤、缺血和移植再灌注可能是导致自限性肾小球变化的原因。